Dimensional Fund Advisors
ABVC icon

Dimensional Fund Advisors’s ABVC BioPharma ABVC Stock Holding History

Dimensional Fund Advisors’s Portfolio ABVC Stock Details ABVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,227
Closed -$11.9K – 3222
2026
Q1 		$11.9K Buy
+12,227
New +$20.2K ﹤0.01% 3214

Other funds holding ABVC

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Dimensional Fund Advisors's ABVC Position: Q2 2026 in Review

Dimensional Fund Advisors sold out of ABVC BioPharma (ABVC) in Q2 2026, closing a stake of 12,227 shares — an estimated $11.9K sold.

Dimensional Fund Advisors first reported a position in ABVC in Q1 2026 and held it in 1 quarter. The position peaked at $11.9K in Q1 2026. 15 funds tracked by Wall St. Rank hold ABVC as of Q2 2026.

  • Dimensional Fund Advisors reported no remaining ABVC BioPharma position as of Q2 2026 after selling out during the quarter.
  • Dimensional Fund Advisors sold 12,227 ABVC BioPharma shares in Q2 2026, an estimated $11.9K.
  • Dimensional Fund Advisors first reported a position in ABVC BioPharma in Q1 2026 and held it in 1 quarter.
  • Dimensional Fund Advisors's ABVC BioPharma position peaked at $11.9K in Q1 2026.
  • 15 funds tracked by Wall St. Rank held ABVC BioPharma as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.